Roy Alon

Roy Alon

Auto-generated profile, based on publicly available information

Roy Alon

Department of Ophthalmology, Meir Medical Center, Kfar-Saba, Israel

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
Tina FelfeliTina Felfeli
Tina Felfeli
RARoy Alon
Roy Alon
RMRebecca Merritt
Rebecca Merritt
MBMichael H. Brent
Michael H. Brent

25 October 2017 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
PCPanos G. Christakis
Panos G. Christakis
RARoy Alon
Roy Alon
MBMichael H. Brent
Michael H. Brent
Migraine with visual aura is a common condition that affects up to 5% of the population during their lifetime. Rasmussen B.K. Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992; 12 (discussion 186): 221-228 Crossref PubMed Scopus (501) Google Scholar Visual symptoms last 5–60 minutes and may range from a fortification spectrum (zigzag figures with scintillating edges) to scotoma without positive phenomena that may resemble visual field loss. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33 : 629-808 Crossref PubMed Scopus (5646) Google Scholar Here we present a case of a patient with a history of migraine who had repeated visual field loss that was erroneously diagnosed as a visual aura and suffered permanent vision loss. A 60-year-old Caucasian male professor with a strong history of migraine with aura presented with a 1-day history of a persistent right inferior visual field defect. He noticed the visual field loss the prior afternoon while reading, which was preceded by a mild right-sided headache that lasted 30 minutes and resolved spontaneously. He denied any other neurological symptoms. He reported hundreds of similar episodes over the past 30 years, which always affected his right eye and caused temporary inferior visual field loss. He saw an ophthalmologist and a neurologist to investigate these episodes and was reassured that it was consistent with migraine with visual aura. His medical history included an idiopathic right Bell’s palsy, which fully resolved without treatment. His medications included aspirin 81 mg daily. He denied any use of phosphodiesterase type 5 inhibitors. He was a nonsmoker. On examination, visual acuity was 20/20 OU. Pupils were equal and reactive to light, with a trace right relative afferent pupillary defect. Dilated fundus examination revealed retinal whitening and associated nerve fibre layer edema along the superotemporal and superonasal retinal arcades (Fig. 1). Retinal thickening extended to the superior macula but spared the fovea. The superior retinal arterial vasculature was dilated compared to the inferior arterial vasculature. A single peripapillary flame-shaped retinal hemorrhage was present, and the optic nerve was normal with no visible emboli and a cup-to-disc ratio of 0.2. Examination of the contralateral eye was unremarkable. Fig. 1 Colour fundus photograph demonstrating whitening of the superior retina in the right eye consistent with a right hemiretinal artery occlusion. View Large Image Figure Viewer Download Hi-res image Download (PPT) The diagnosis of a right superior hemiretinal artery occlusion was made clinically, and a fluorescein angiogram was performed. The arterial phase demonstrated complete filling of the arteries with no emboli, focal stenosis, or vasospasm noted. The right superior arterial vasculature appeared dilated and filled 4 seconds earlier than the inferior arterial vasculature (Fig. 2). The midphase and late phase were normal with no evidence of leakage. Optical coherence tomography revealed a thickened and hyper-reflective retinal nerve fibre layer in the superior macula consistent with edema (Fig. 3). Fig. 2 Late arteriovenous phase showing complete filling of the entire arterial and venous vasculature. The superior arterial vasculature (red arrow) is dilated compared with the inferior vasculature (green arrow). View Large Image Figure Viewer Download Hi-res image Download (PPT) Fig. 3 Optical coherence tomography demonstrating hyper-reflectivity of the retinal nerve fibre layer (red arrow) extending to the superior macula of the right eye and associated thickening. View Large Image Figure Viewer Download Hi-res image Download (PPT) The patient was referred to the stroke prevention clinic for assessment for vascular risk factors and possible embolic sources. Blood pressure, heart rate, and electrocardiogram were normal. Bloodwork findings, including complete blood count, coagulation profile, erythrocyte sedimentation rate, and fasting lipids, were within normal limits. Computed tomography of the head with contrast was unremarkable. Transthoracic echocardiography was normal. The patient was seen 1 month later, and his visual acuity remained 20/20 OU, with improvement in the superior retinal edema of the right eye. He reported no interim episodes of visual obscuration, although his right inferior visual field defect persisted. To our knowledge, this is the first reported case of a patient with a clear history of a recurrent monocular visual field defect associated with migraine that developed an arterial occlusion corresponding to that vascular distribution. His visual disturbance always occurred in his right eye and always caused an inferior visual field defect, suggesting a predisposition of the superior retinal vasculature to occlusion. The mechanism of occlusion is presumed to be caused by vasospasm given the associated features of migraine, number of recurrences, and negative work-up for alternate sources. Furthermore, the presence of a dilated superior arterial vasculature after occlusion is characteristic of vasospasm, and in contrast to the attenuated arterial vasculature expected after an embolic or thrombotic occlusion. Abdul-Rahman A.M. Gilhotra J.S. Selva D. Dynamic focal retinal arteriolar vasospasm in migraine. Indian J Ophthalmol. 2011; 59 : 51-53 Crossref PubMed Scopus (22) Google Scholar ,  Ota I. Kuroshima K. Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol. 2013; 131 : 1481-1482 Crossref PubMed Scopus (13) Google Scholar Retinal migraine is defined by the International Classification of Headache Disorders-3B as at least 2 episodes of monocular visual disturbance (positive and/or negative phenomena) associated with at least 2 features of migraine headache (aura spreading over ≥5 minutes, lasting 5–60 minutes, or accompanied/followed by a headache within 60 minutes). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33 : 629-808 Crossref PubMed Scopus (5646) Google Scholar Other causes of transient monocular visual loss, including amaurosis fugax, must be excluded. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33 : 629-808 Crossref PubMed Scopus (5646) Google Scholar Unlike migraine with visual aura, which is a bilateral process resulting from cortical spreading depression within the brain, retinal migraine has been postulated to be caused by vasospasm of the vascular circulation of the eye. Case reports have demonstrated focal vasospasm during acute episodes of retinal migraine using fundus photography and videography. Abdul-Rahman A.M. Gilhotra J.S. Selva D. Dynamic focal retinal arteriolar vasospasm in migraine. Indian J Ophthalmol. 2011; 59 : 51-53 Crossref PubMed Scopus (22) Google Scholar ,  Ota I. Kuroshima K. Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol. 2013; 131 : 1481-1482 Crossref PubMed Scopus (13) Google Scholar ,  Burger S.K. Saul R.F. Selhorst J.B. Thurston S.E. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991; 325 : 870-873 Crossref PubMed Scopus (87) Google Scholar ,  Kosmorsky G.S. Angiographically documented transient monocular blindness: retinal migraine?. Br J Ophthalmol. 2013; 97 (15): 1604-1606 Crossref PubMed Scopus (8) Google Scholar Although retinal migraines usually resolve spontaneously and completely, a subset of patients are left with permanent vision loss as a result of vascular compromise, including central retinal artery occlusion, cilioretinal artery occlusion, or ischemic optic neuropathy. Grosberg B.M. Solomon S. Friedman D.I. Lipton R.B. Retinal migraine reappraised. Cephalalgia. 2006; 26 : 1275-1286 Crossref PubMed Scopus (61) Google Scholar The pathophysiology may parallel a cerebral infarction, which very rarely occurs during a migraine. In a review of 46 cases of retinal migraine, Grosberg et al. Grosberg B.M. Solomon S. Friedman D.I. Lipton R.B. Retinal migraine reappraised. Cephalalgia. 2006; 26 : 1275-1286 Crossref PubMed Scopus (61) Google Scholar found that 21 of 46 (46%) had permanent vision loss because of prolonged vascular compromise. This patient cohort had a mean age of 25 years (range 7–54 years) and very low rates of vascular risk factors. The time course from the first episode of transient vision loss to the development of permanent vision loss ranged from 1 year to 52 years. Several cases are reported of patients on beta-blockers for migraine who developed permanent vision loss due to vascular occlusion. Pandit J.C. Fritsche P. Permanent monocular blindness and ocular migraine. J R Soc Med. 1997; 90 : 691-692 Crossref PubMed Scopus (8) Google Scholar As a result, some authors have suggested avoiding beta-blockers for their potential for arteriolar constriction, Grosberg B.M. Solomon S. Friedman D.I. Lipton R.B. Retinal migraine reappraised. Cephalalgia. 2006; 26 : 1275-1286 Crossref PubMed Scopus (61) Google Scholar although the mechanism is uncertain given the lack of adrenergic innervation of the proximal retinal vasculature. Laties A.M. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol. 1967; 77 : 405-409 Crossref PubMed Scopus (167) Google Scholar Calcium channel blockers use has been proposed based on their efficacy in vasospasm-associated amaurosis fugax. Winterkorn J.M. Kupersmith M.J. Wirtschafter J.D. Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993; 329 : 396-398 Crossref PubMed Scopus (115) Google Scholar In conclusion, retinal migraine is a monocular visual disturbance found in patients with migraine that has a presumed pathophysiology of retinal vasospasm. It is a diagnosis of exclusion, and amaurosis fugax must be ruled out. It should not be confused with “ocular migraine,” which is a misleading term used to describe migraine with visual aura. Although there is a paucity of evidence on preventative treatment, our patient may have benefited from antimigraine prophylaxis given that his vision loss was preceded by hundreds of transient episodes.